NAT10 mediated Polycystic ovary syndrome through the ac4C modification of CXCL14 DOI
Ding Wang, Hui Li, Lingling Wang

et al.

The Journal of Steroid Biochemistry and Molecular Biology, Journal Year: 2025, Volume and Issue: unknown, P. 106767 - 106767

Published: April 1, 2025

Language: Английский

NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer DOI Creative Commons
Xiaona Chen, Yi Hao, Yong Liu

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(32)

Published: Oct. 11, 2023

Immunotherapy has recently emerged as the predominant therapeutic approach for cervical cancer (CCa), driven by groundbreaking clinical achievements of immune checkpoint inhibitors (ICIs), such anti-PD-1/PD-L1 antibodies. N4-acetylcytidine (ac4C) modification, catalyzed NAT10, is an important posttranscriptional modification mRNA in cancers. However, its impact on immunological dysregulation and tumor immunotherapy response CCa remains enigmatic. Here, a significant increase NAT10 expression tissues initially observed that clinically associated with poor prognosis. Subsequently, it found HOXC8 activated binding to promoter, thereby stimulating ac4C FOXP1 enhancing translation efficiency, eventually leading induction GLUT4 KHK expression. Moreover, NAT10/ac4C/FOXP1 axis activity resulted increased glycolysis continuous lactic acid secretion cells. The acid-enriched microenvironment (TME) further contributed amplifying immunosuppressive properties tumor-infiltrating regulatory T cells (Tregs). Impressively, knockdown enhanced efficacy PD-L1 blockade-mediated regression vivo. Taken together, findings revealed oncogenic role initiating crosstalk between cell immunosuppression, which can be target synergistic PD-1/PD-L1 blockade CCa.

Language: Английский

Citations

42

The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways DOI Creative Commons
Dengxiong Li, Fanglin Shao,

Qingxin Yu

et al.

Cell Communication and Signaling, Journal Year: 2024, Volume and Issue: 22(1)

Published: Aug. 19, 2024

Drug resistance remains a significant challenge in cancer treatment. Recently, the interactions among various cell types within tumor microenvironment (TME) have deepened our understanding of mechanisms behind treatment resistance. Therefore, this review aims to synthesize current research focusing on infiltrating cells and drug suggesting that targeting TME could be viable strategy combat issue. Numerous factors, including inflammation, metabolism, senescence, hypoxia, angiogenesis, contribute Overexpression STAT3 is commonly associated with drug-resistant or stromal cells. Current often generalizes impact resistance, lacking specificity statistical robustness. Thus, future should take notice issue aim provide high-quality evidence. Despite existing limitations, overcome therapy hold promising valuable potential.

Language: Английский

Citations

11

Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis DOI Creative Commons
Qiang Wang, Mengmeng Li, Chen Chen

et al.

Theranostics, Journal Year: 2025, Volume and Issue: 15(6), P. 2428 - 2450

Published: Jan. 20, 2025

Rationale: Abnormal metabolic states contribute to a variety of diseases, including cancer. RNA modifications have diverse biological functions and are implicated in cancer development, gastric (GC). However, the direct relationship between glucose homeostasis 4-acetylcytosine (ac4C) modification GC remains unclear. Methods: The prognostic value acetyltransferase NAT10 expression was evaluated human cohort. Additionally, preoperative PET/CT data from patients Micro-PET/CT imaging mice were employed assess metabolism. role investigated through various experiments, xenografts, organoids, conditional knockout (cKO) mouse model. underlying mechanisms examined using dot blotting, immunofluorescence staining, co-immunoprecipitation, high-throughput sequencing, among other techniques. Results: Glucose deprivation activates autophagy-lysosome pathway, leading degradation by enhancing its interaction with sequestosome 1 (SQSTM1)/microtubule-associated protein light chain 3 alpha (LC3) complex, ultimately resulting reduction ac4C modification. Furthermore, levels elevated tissues correlate poor prognosis. A strong correlation exists 18F-FDG uptake patients. drives glycolytic metabolism carcinogenesis vitro vivo. Mechanistically, stimulates at intersection coding sequence (CDS) 3' untranslated region (3'UTR) hexokinase 2 (HK2) mRNA, stability activating thereby driving tumorigenesis. Conclusion: Our findings highlight critical crosstalk epitranscriptome carcinogenesis. This finding offers potential strategy targeting NAT10/HK2 axis for treatment patients, especially those highly active

Language: Английский

Citations

1

Targeting N4‐acetylcytidine suppresses hepatocellular carcinoma progression by repressing eEF2‐mediated HMGB2 mRNA translation DOI Creative Commons
Hailing Liu, Lei Xu, Shiwei Yue

et al.

Cancer Communications, Journal Year: 2024, Volume and Issue: 44(9), P. 1018 - 1041

Published: July 19, 2024

Abstract Background N4‐acetylcytidine (ac4C) represents a novel messenger RNA (mRNA) modification, and its associated acetyltransferase N‐acetyltransferase 10 (NAT10) plays crucial role in the initiation progression of tumors by regulating mRNA functionality. However, hepatocellular carcinoma (HCC) development prognosis is largely unknown. This study aimed to elucidate NAT10‐mediated ac4C HCC provide promising therapeutic approach. Methods The levels were evaluated dot blot ultra‐performance liquid chromatography‐tandem mass spectrometry with harvested tissues. expression NAT10 was investigated using quantitative real‐time polymerase chain reaction, western blotting, immunohistochemical staining across 91 cohorts patients. To explore underlying mechanisms NAT10‐ac4C HCC, we employed comprehensive approach integrating acetylated immunoprecipitation sequencing, sequencing ribosome profiling analyses, along immunoprecipitation, pull‐down, spectrometry, site‐specific mutation analyses. drug affinity responsive targets stability, cellular thermal shift assay, surface plasmon resonance assays performed assess specific binding Panobinostat. Furthermore, efficacy targeting for treatment elucidated through vitro experiments cells vivo mouse models. Results Our investigation revealed significant increase both level HCC. Notably, elevated poor outcomes Functionally, silencing suppressed proliferation metastasis vivo. Mechanistically, stimulates modification within coding sequence (CDS) high mobility group protein B2 (HMGB2), which subsequently enhances HMGB2 translation facilitating eukaryotic elongation factor 2 (eEF2) sites on mRNA's CDS. Additionally, high‐throughput compound library screening Panobinostat as potent inhibitor modification. inhibition significantly attenuated growth Conclusions identified oncogenic epi‐transcriptome axis involving NAT10‐ac4C/eEF2‐HMGB2, pivotal metastasis. validates potential this treatment.

Language: Английский

Citations

8

Dissecting the oncogenic properties of essential RNA-modifying enzymes: a focus on NAT10 DOI
Mahmood Hassan Dalhat, Sharath Narayan,

Hannah Serio

et al.

Oncogene, Journal Year: 2024, Volume and Issue: 43(15), P. 1077 - 1086

Published: Feb. 26, 2024

Language: Английский

Citations

5

Acetyl-CoA-dependent ac4C acetylation promotes the osteogenic differentiation of LPS-stimulated BMSCs DOI

Yujia Bai,

Wenjie Zhang, Lili Hao

et al.

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 133, P. 112124 - 112124

Published: April 24, 2024

Language: Английский

Citations

5

NAT10-mediated ac4C acetylation of TFRC promotes sepsis-induced pulmonary injury through regulating ferroptosis DOI Creative Commons

Pengcheng Xing,

Minjie Zhou,

Jian Sun

et al.

Molecular Medicine, Journal Year: 2024, Volume and Issue: 30(1)

Published: Sept. 9, 2024

Language: Английский

Citations

5

NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction DOI Creative Commons
Guozheng Li, Xin Ma,

Shiyao Sui

et al.

Journal of Experimental & Clinical Cancer Research, Journal Year: 2024, Volume and Issue: 43(1)

Published: Oct. 4, 2024

Language: Английский

Citations

5

Lactate-Induced CCL8 in Tumor-Associated Macrophages Accelerates the Progression of Colorectal Cancer through the CCL8/CCR5/mTORC1 Axis DOI Open Access
Hui Zhou, Jiayi Yao,

Zhaozhong Zhong

et al.

Cancers, Journal Year: 2023, Volume and Issue: 15(24), P. 5795 - 5795

Published: Dec. 11, 2023

Tumor-associated macrophages (TAMs) play a pivotal role in shaping the tumor microenvironment. Lactic acid (LA) has been identified as an influential factor promoting immune escape and progression. However, mechanisms through which LA modulates TAMs colorectal cancer (CRC) remain poorly understood. We used qRT-PCR to quantify expression of LA-related genes (LDHA LAMP2) CRC tissues adjacent nontumor (n = 64). The biological effects on tumors were evaluated via qRT-PCR, Western blot, RNA-seq, wound healing assay, colony formation assay vitro, allograft mouse models vivo. found LDHA LAMP2 was highly elevated regions positively associated with poor clinical stage CRC. A high concentration generated under hypoxia; it could promote progression metastasis involvement macrophages. inhibition release impaired this protumor phenomenon. Mechanically, induced M2 AKT/ERK signaling pathway; subsequently, secreted CCL8 facilitated proliferation cells by activating CCL8/CCR5/mTORC1 axis. This effect inhibited antagonist or knockdown CCR5. In conclusion, lactate-induced accelerated

Language: Английский

Citations

12

m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation DOI
Yujiao Liu, Li Jia, Jie Xu

et al.

Oncogene, Journal Year: 2024, Volume and Issue: 43(48), P. 3498 - 3516

Published: Oct. 10, 2024

Language: Английский

Citations

4